Abstract
The present disclosure relates to method of obtaining high purity glucans, in particular yeast glucans with immunomodulatory properties, including vaccine adjuvant properties for the use as adjuvant in vaccines.
Original language | English |
---|---|
Patent number | EP4291241A1 |
IPC | A61K47/36,C08B37/00,C12P19/04 |
Priority date | 14/02/21 |
Filing date | 11/02/23 |
Publication status | Submitted - 11 Feb 2023 |